Cite
HARVARD Citation
Sora, F. et al. (2021). Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b‐precursor acute lymphoblastic leukaemia: Case reports and literature review. Pediatric blood & cancer. 68 (7), p. n/a. [Online].